Dinesh Patel
Founding Managing Director @ vSpring Capital
Dinesh Patel is a Series A investor at vSpring Capital focused on Energy and Finance. Dr. Patel co-founded vSpring Capital (now Signal Peak Ventures) in 2000 and has been a founding managing director since its formation. Prior to Signal Peak Ventures, Dr. Patel was an active angel investor in over 20 biotech and technology companies. From 1985 – 1999 Dr. Patel served as Co-Founder, Chairman of The Board of Directors and President& CEO of TheraTech, Inc., a biotechnology company which he took public and eventually sold to Watson Pharmaceuticals. From 1999 to 2004 he was the Founder, Chairman, President & CEO of Ashni Naturaceuticals, Inc., a company that specializes in the research, development and marketing of clinically tested and patent-protected naturaceutical products. In 1999, Dr. Patel co-founded and was the Chairman of Salus Therapeutics, Inc., a biotechnology company focused on the research and development of nucleic acid-based therapeutics, including antisense and gene therapy drugs. He currently holds 15 U.S. Patents and Foreign Counterparts.Dr. Patel serves on several non-profit boards, and has won numerous awards including; 2006 Utah Technology Council Hall of Fame Inductee, 2006 Ellis Island Medal of Honor, US Small Business Administration’s Business Achiever Award, Scientific and Technology Award (State of Utah), Entrepreneur of the Year Award (Mountain West Venture Group) and Scientific and Technology Development Pioneer of Progress Award, to name a few. He is also a charter member of The Indus Entrepreneurs (TiE).Dr. Patel served as co-chair of Governor Huntsman’s transition. He is the Chairman of the USTAR Governing Authority board.Born and raised in Zambia, Africa, Dr. Patel received his bachelor’s degree in Pharmacy at Gujarat University located in Ahmedabad, Gujarat, India, his master’s degree from the Philadelphia College of Pharmacy, and his Ph.D. in Physical Pharmacy from the University of Michigan.Dr. Patel led the firm’s investments in American Academy, Athena Feminine Technologies, Axial Biotech, Coherex Medical, Exagen Diagnostics, Mirabilis Medica, Numira Biosciences, Lineagen, Q Therapeutics, ZARS Pharma and Salus Therapeutics which was acquired by Genta (NASDAQ: GNTA) for $30 million.
- Total investments:
- 4
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Dinesh Patel invests in
Stages Dinesh Patel invests in
Countries Dinesh Patel invests in
Investment Focus
Industry
- Energy 1 (25%)
- Finance 1 (25%)
- Hospital 1 (25%)
- Biopharma 1 (25%)
- Health Care 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Vutility
|
Vutility is the leading provider of real-time, high-resolution, energy monitoring solutions - enabling businesses to optimize their energy consumption and improve operational efficiencies. Using its innovative and affordable proprietary HotDrop™ technology, companies across a range of retail and commercial industries gain relevant and timelyinsights into their energy usage. | $1.5M / Seed / Jul 14, 2016 | |
Coherex Medical
|
Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO. The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in2006. The company is based in Salt Lake City, Utah. | $16.5M / Series B / Oct 12, 2009 | |
|
Coherex Medical
|
Coherex Medical, Inc. develops medical devices for addressing the structural heart disease conditions. It offers patent foramen ovale (PFO) closure system, which is designed to stimulate tissue in-growth to ensure long-term closure of the PFO. The company was founded as Proximare, Inc. in 2003 and changed its name to Coherex Medical, Inc. in2006. The company is based in Salt Lake City, Utah. | $8.5M / Series A / Apr 19, 2007 | |
Numira Biosciences
|
Numira Biosciences, Inc., a contract research organization, provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. It offers Virtual Histology for soft tissue imaging applications, such as atherosclerosis, osteoarthritis, heart defects, pulmonary diseases, developmental biology, and phenotyping;and high-resolution bone imaging tools to analyze and characterize the skeletal anatomy and bones of animal models. The company also provides image processing and visual analytics solutions; AltaViewer visualization software, a visualization tool for use in non-clinical environments to view, manipulate, and export images of small animal datasets for research purposes; and imaging chamber, a multi-modality imaging chamber that facilitates the co-registration of anatomical and functional images by means of sequential multi-modal imaging. | $2.5M / Series A / Mar 21, 2007 |
Co-Investors
About vSpring Capital
vSpring Capital and Signal Peak Ventures, both based in Salt Lake City, are combining as equal partners in a new investment firm that, effective immediately, will operate under the Signal Peak Ventures name, both companies announced Tuesday. No money was exchanged.vSpring is a traditional early-stage venture capital firm with over $350 millionof committed capital under management. Specifically, they target information technology and life sciences companies headquartered in the Intermountain West region. They look for companies with the potential to transform their markets and create lasting value. Their primary areas of focus include enterprise software, networking and communications, security software, Internet, mobile computing, drug discovery, drug delivery, diagnostics, and medical devices, all markets where the firm has deep experience.Their strategy is to be the first investor in these companies and to provide a level of operational assistance that creates additional value. They take a labor-intensive, service-oriented approach by making early introductions to key customers and strategic partners and helping to recruit top executives and co-investors.
vSpring Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Dinesh Patel
Founding Managing Director
|
|||
Brandon Tidwell
Founding Partner & Managing Director
|
|||
|
David Anderson
CFO
|
|||
|
Michael S. Paul
Venture Partners
|
|||
Michael S. Paul
Venture Partners
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Dinesh Patel invest in?
Dinesh Patel invests primarily in Energy, Finance and Hospital startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
